数据显示在血糖控制方面，该药物优于Bristol-Myers Squibb的byetta和Merck公司的Januvia和metformin等药物。在今年的晚些时候，公司将寻求FDA批准这种每周 ...

Januvia (sitagliptin) is a prescription drug that’s used to treat type 2 diabetes in adults. The drug comes as an oral tablet. It’s usually taken once per day. Januvia is used in adults to ...

Januvia (sitagliptin) is a prescription oral tablet that’s taken to help manage blood sugar levels in people with type 2 diabetes. Januvia can cause mild to serious side effects, such as headache.

NEW YORK (Reuters) - Merck & Co Inc's fast growing diabetes drug Januvia proved effective in helping patients lower blood sugar in combination with Takeda's Actos, and when used along with insulin ...

April 27 (Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday ...

Januvia and Janumet are Merck & Co.’s (MRK) blockbuster diabetes drugs. They’re used to lower blood sugar levels in patients with Type 2 diabetes. Combined sales for these drugs totaled ~$1.4 ...

Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now. By Andrew Jacobs The Food and Drug Administration said ...

Januvia (sitagliptin) is a medication for type 2 diabetes. Along with diet and exercise, it can help lower blood sugar levels. Medicare Part D will generally cover prescription drugs, like Januvia.

Merck plays 'to win' in one of its first launches since implementing a new cost-cutting model. Januvia's dramatic launch was all about speed. Within 24 hours of approval, physician consultants began ...

In 2025, the deductible cannot exceed $590. Januvia (sitagliptin) is a prescription-only medication for type 2 diabetes. It can work alongside diet and exercise to help lower blood sugar (glucose ...